Newsroom
Sorted by: Latest
-
Citibank UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- Re: Atlas Funding 2025-2 plc GBP 3,420,000.00 MATURING: 20-Jul-2067 ISIN: XS3212017175 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 20-Apr-2026 TO 20-May-2026 HAS BEEN FIXED AT 6.81 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 20-May-2026 WILL AMOUNT TO: GBP 20,136.22 PER GBP 3,599,998.08 DENOMINATION ...
-
HSBC Bank Plc UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- 12-May-2026 Issue: Newday Funding Master Issuer Plc Series 2024-1 Class B RegS XS2768182524 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 15-April-2026 Date To: 15-May-2026 Record Date: 14-May-2026 Value Date: 15-May-2026 Benchmark Rate: 3.73528% Margin: 1.65% Total Rate: 5.38528% Number of Days: 30 Day Count: Actual / 365L Interest Frequency: Monthly Total Amount Due: GBP 82...
-
HSBC Bank Plc UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- 12-May-2026 Issue: Newday Funding Master Issuer Plc Series - Series 2024-3 Class A1 144A XS2909751740 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 15-April-2026 Date To: 15-May-2026 Record Date: 14-May-2026 Value Date: 15-May-2026 Benchmark Rate: 3.73528102% Margin: 0.9% Total Rate: 4.63528102% Number of Days: 30 Day Count: Actual / 365L Interest Frequency: Monthly Total Amo...
-
Riassunto: Incyte rende noto che oltre 20 abstract sono stati accettati per la presentazione al Congresso 2026 della European Hematology Association (EHA)
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) oggi ha reso noto che i dati provenienti da principali programmi delle sue divisioni di Ematologia e Oncologia saranno presentati al Congresso 2026 della European Hematology Association (EHA), che si terrà dall'11 al 14 giugno a Stoccolma, Svezia. Il testo originale del presente annuncio, redatto nella lingua di partenza, è la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodità del lettore e devono rinviare a...
-
Resumen: Incyte anuncia que logró la aceptación de más de 20 resúmenes para su presentación en el Congreso 2026 de la European Hematology Association (EHA)
WILMINGTON, Delaware--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) anunció hoy que se presentarán datos de programas clave en sus franquicias de hematología y oncología en el Congreso 2026 de la European Hematology Association (EHA), que se llevará a cabo del 11 al 14 de junio en Estocolmo (Suecia). El comunicado en el idioma original es la versión oficial y autorizada del mismo. Esta traducción es solamente un medio de ayuda y deberá ser comparada con el texto en idioma original, que es la única vers...
-
Incyte annonce que plus de 20 résumés ont été retenus en vue d'une présentation lors du Congrès 2026 de l'Association européenne d'hématologie (EHA)
WILMINGTON, Delaware--(BUSINESS WIRE)--Incyte (Nasdaq : INCY) a annoncé aujourd'hui la présentation des données de ses programmes clés dans les domaines de l'hématologie et de l'oncologie à l'occasion du Congrès 2026 de l'Association européenne d'hématologie (EHA), qui aura lieu du 11 au 14 juin 2026 à Stockholm, en Suède. « Les données très complètes qui seront présentées lors du Congrès 2026 de l’EHA témoignent des progrès continus de notre pipeline en hématologie et en oncologie, ainsi que d...
-
Samenvatting: Incyte maakt bekend dat meer dan 20 abstracts zijn geselecteerd voor presentatie op het congres van de European Hematology Association (EHA) in 2026
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) heeft vandaag bekendgemaakt dat gegevens uit belangrijke programma’s binnen zijn hematologie- en oncologie-divisies zullen worden gepresenteerd tijdens het congres van de European Hematology Association (EHA) 2026, dat van 11 tot en met 14 juni 2026 plaatsvindt in Stockholm, Zweden. Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de b...
-
Damon Henry, Adam Mohamed, Brent McLaughlin of Asylon Named Entrepreneur Of The Year® 2026 Greater Philadelphia Finalist by EY US
PHILADEPHIA--(BUSINESS WIRE)--Damon Henry, CEO and Co-Founder, Adam Mohamed, CTO and Co-Founder, and Brent McLaughlin, COO and Co-Founder, of Asylon have been named finalists for the Entrepreneur Of The Year 2026 Greater Philadelphia Award by Ernst & Young LLP (EY US). Now in its 41st year, the Entrepreneur Of The Year program celebrates the bold leaders who disrupt markets through the world’s most ground-breaking companies, revolutionizing industries and uplifting communities. The program...
-
Paragon Mortgages (No.12) Plc UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- Re: PARAGON MORTGAGES NO 12 PLC EUR 126,000,000.00 MATURING: 15-Nov-2038 ISIN: XS0261648850 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 15-May-2026 TO 17-Aug-2026 HAS BEEN FIXED AT 2.76 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 17-Aug-2026 WILL AMOUNT TO: EUR 127.52 PER EUR 17,675.62 DENOMINATION ...
-
Incyte gibt bekannt, dass mehr als 20 Abstrakte für die Präsentation auf dem Kongress der European Hematology Association (EHA) 2026 angenommen wurden
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) gab heute bekannt, dass Daten aus wichtigen Programmen seiner Geschäftsbereiche Hämatologie und Onkologie auf dem Kongress der European Hematology Association (EHA) 2026 vorgestellt werden, der vom 11. bis 14. Juni 2026 in Stockholm, Schweden, stattfindet. „Die Bandbreite der Daten, die auf dem EHA-Kongress 2026 vorgestellt werden, unterstreicht den kontinuierlichen Fortschritt unserer Pipeline in den Bereichen Hämatologie und Onkologie so...